Comment on a systematic review of randomized trials of peginterferon alpha-2a versus peginterferon alpha-2b in chronic hepatitis C

Hepatology. 2011 Jun;53(6):2151. doi: 10.1002/hep.24165. Epub 2011 Apr 29.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Meta-Analysis
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Comorbidity
  • HIV Infections / epidemiology*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Polyethylene Glycols / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b
  • peginterferon alfa-2a